{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:48:36Z","timestamp":1767134916444,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd010561","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,4,24]],"date-time":"2014-04-24T00:00:00Z","timestamp":1398297600000}}],"reference-count":88,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010561.pub2","type":"journal-article","created":{"date-parts":[[2014,4,24]],"date-time":"2014-04-24T13:12:37Z","timestamp":1398345157000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B"],"prefix":"10.1002","volume":"2015","author":[{"given":"Abha H","family":"Athale","sequence":"first","affiliation":[{"name":"McMaster University; Department of Health Sciences; 1280 Main Street West Hamilton ON Canada L8S 4L8"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maura","family":"Marcucci","sequence":"additional","affiliation":[{"name":"McMaster University; Department of Health Sciences; 1280 Main Street West Hamilton ON Canada L8S 4L8"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Iorio","sequence":"additional","affiliation":[{"name":"McMaster University; Department of Clinical Epidemiology and Biostatistics; 1280 Main Street West CRL - 140 Hamilton ON Canada L8S 4K1"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,4,24]]},"reference":[{"key":"10.1002\/14651858.CD010561.pub2-BIB0001|cit1","first-page":"57","article-title":"International randomized immune tolerance (ITI) study: progress report [abstract]","volume":"12 Suppl 2","author":"DiMichele","year":"2006","journal-title":"Haemophilia"},{"issue":"10","key":"10.1002\/14651858.CD010561.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1111\/j.1538-7836.2006.02127.x","article-title":"The international immune tolerance study: a multicenter prospective randomized trial in progress","volume":"4","author":"DiMichele","year":"2006","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0003|cit3","first-page":"845","article-title":"The principal results of the international immune tolerance study: Morbidity [abstract]","volume":"9","author":"Hay","year":"2011","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"6","key":"10.1002\/14651858.CD010561.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1182\/blood-2011-08-369132","article-title":"The principal results of the International Immune Tolerance Study: a randomized dose comparison","volume":"119","author":"Hay","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1002\/14651858.CD010561.pub2-BIB0005|cit5","first-page":"405","article-title":"International prospective randomised immune tolerance (ITI) study: interim analysis of therapeutic efficacy and safety [abstract]","volume":"16","author":"Hay","year":"2010","journal-title":"Haemophilia"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0006|cit6","first-page":"57","article-title":"International immune tolerance (ITI) study: frequency of central venous line infection and effect on ITI outcome [abstract]","volume":"12 Suppl 2","author":"Hay","year":"2006","journal-title":"Haemophilia"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0007|cit7","doi-asserted-by":"crossref","unstructured":"Astermark J Donfield SM DiMichele DM Gringeri A Gilbert SA Waters J A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study Blood 2007 546 51","DOI":"10.1182\/blood-2006-04-017988"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0008|cit8","first-page":"69, Abstract no","article-title":"Treatment of inhibitors in children with severe haemophilia B [abstract]","volume":"16 Suppl 4","author":"Baker","year":"2010","journal-title":"Haemophilia"},{"issue":"6","key":"10.1002\/14651858.CD010561.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/j.1365-2516.1999.00354.x","article-title":"Induction of immune tolerance with recombinant factor VIII in haemophilia A patients with inhibitors","volume":"5","author":"Batlle","year":"1999","journal-title":"Haemophilia"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0010|cit10","first-page":"521, Abstract n","article-title":"ITI experience in hemophilia A patients with inhibitors and a poor prognosis [abstract]","volume":"7 Suppl 2","author":"Berger","year":"2009","journal-title":"Journal of Thrombosis & Haemostasis"},{"issue":"2","key":"10.1002\/14651858.CD010561.pub2-BIB0012|cit11","first-page":"359","article-title":"The FEIBA\u00ae Novoseven\u00ae comparative study (FENOC): a randomized evaluation of by-passing agents in hemophilia complicated by inhibitors [abstract]","volume":"12","author":"Berntorp","year":"2006","journal-title":"Haemophilia"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0011|cit12","doi-asserted-by":"crossref","unstructured":"Berntorp E Donfield S Waters J Mattson E DiMichele D Gringeri A The FEIBA\u00ae Novoseven\u00ae comparative study (FENOC) - a randomized evaluation of by-passing agents in hemophilia complicated by inhibitors [abstract] Blood 2005 Abstract no: 324","DOI":"10.1182\/blood.V106.11.324.324"},{"issue":"4","key":"10.1002\/14651858.CD010561.pub2-BIB0013|cit13","first-page":"539","article-title":"Low-dose immune tolerance induction in haemophilia a children with inhibitors","volume":"8","author":"Carneiro","year":"2002","journal-title":"Haemophilia"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0014|cit14","unstructured":"Ewenstein BM Hoots WK Lusher JM DiMichele D White GC Adelman B Inhibition of CD40 ligand (CD154) in the treatment of factor VIII inhibitors Haematologica 2000 35 9"},{"issue":"1","key":"10.1002\/14651858.CD010561.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.1988.03720010043038","article-title":"Induction of immune tolerance to factor VIII in hemophiliacs with inhibitors","volume":"259","author":"Ewing","year":"1988","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD010561.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1056\/NEJMoa1208024","article-title":"Online Supplement to: Factor VIII products and inhibitor development in severe hemophilia A.\u00a0","volume":"368","author":"Gouw","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD010561.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00043426-199221000-00013","article-title":"Induction of immune tolerance in patients with hemophilia A and inhibitors","volume":"14","author":"Valdez","year":"1992","journal-title":"American Journal of Pediatric Hematology\/Oncology"},{"issue":"4","key":"10.1002\/14651858.CD010561.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2516.2004.00907.x","article-title":"Effectiveness of factor VIII infusions in haemophilia A patients with high responding inhibitors","volume":"10","author":"Kasuda","year":"2004","journal-title":"Haemophilia"},{"issue":"1","key":"10.1002\/14651858.CD010561.pub2-BIB0019|cit19","first-page":"87","article-title":"Immune tolerance induction in haemophilic children with factor VIII inhibitors","volume":"36","author":"Klukowska A. Laguna P. Obitko-Pludowska A. Niebzielska","year":"2005","journal-title":"Acta Haematologica Polonica"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0020|cit20","first-page":"74","article-title":"Immune tolerance induction in Polish children with severe hemophilia A and inhibitor-high responders: 17P45 [abstract]\u00a0","volume":"16 Suppl 4","author":"Klukowska","year":"2010","journal-title":"Haemophilia"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0021|cit21","first-page":"91","article-title":"The results of immune tolerance induction in polish children with severe hemophilia A complicated by factor VIII inhibitor [abstract]","volume":"18","author":"Klukowska","year":"2012","journal-title":"Haemophilia"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0022|cit22","first-page":"1069-1070, Abst","article-title":"Immune tolerance induction in children with severe hemophilia A and inhibitor in Poland\u00a0[abstract]","volume":"11 Suppl 2","author":"Klukowska","year":"2013","journal-title":"Journal of Thrombosis & Haemostasis"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0023|cit23","doi-asserted-by":"crossref","unstructured":"Konkle BA Ebbesen LS Erhardtsen E Bianco RP Lissitchkov T Rusen L Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors Journal of Thrombosis and Haemostasis 2007 1904 13","DOI":"10.1111\/j.1538-7836.2007.02663.x"},{"issue":"4","key":"10.1002\/14651858.CD010561.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2516.1996.tb00141.x","article-title":"Immune tolerance induction in haemophiliacs with inhibitor to FVIII: High- or low-dose programme","volume":"2","author":"Kucharski","year":"1996","journal-title":"Haemophilia"},{"issue":"1","key":"10.1002\/14651858.CD010561.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2516.2007.01560.x","article-title":"Immune tolerance therapy utilizing factor VIII\/von Willebrand factor concentrate in haemophilia A patients with high titre factor VIII inhibitors","volume":"14","author":"Kurth","year":"2008","journal-title":"Haemophilia"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0026|cit26","doi-asserted-by":"crossref","unstructured":"Lusher JM Shapiro SS Palascak JE Rao AV Levine PH Blatt PM Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial New England Journal of Medicine 1980 421 5","DOI":"10.1056\/NEJM198008213030803"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0027|cit27","doi-asserted-by":"crossref","unstructured":"Lusher JM Blatt PM Penner JA Aledort LM Levine PH White GC Autoplex versus proplex: a controlled, double-blind study of effectiveness in acute hemarthroses in hemophiliacs with inhibitors to factor VIII Blood 1983 1135 8","DOI":"10.1182\/blood.V62.5.1135.1135"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0028|cit28","doi-asserted-by":"crossref","unstructured":"Lusher JM Roberts HR Davignon G Joist JH Smith H Shapiro A A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study Group Haemophilia 1998 790 8","DOI":"10.1046\/j.1365-2516.1998.00209.x"},{"issue":"4","key":"10.1002\/14651858.CD010561.pub2-BIB0029|cit29","first-page":"543","article-title":"Successful induction of immune tolerance in children","volume":"8","author":"Manco-Johnson","year":"2002","journal-title":"Haemophilia"},{"issue":"3","key":"10.1002\/14651858.CD010561.pub2-BIB0030|cit30","first-page":"225","article-title":"Immune tolerance in hemophilia and treatment of hemophiliacs with an inhibitor","volume":"86","author":"Mariani","year":"2001","journal-title":"Haematologica"},{"issue":"3","key":"10.1002\/14651858.CD010561.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/hae.12077","article-title":"Late immune tolerance induction in haemophilia A patients","volume":"19","author":"Meeks","year":"2013","journal-title":"Haemophilia"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0032|cit32","first-page":"69","article-title":"Induction of immune tolerance in hemophiliacs with inhibitors by combined treatment with i.v. IgG, cyclophosphamide and factor VIII or IX","volume":"324","author":"Nilsson","year":"1990","journal-title":"Progress in clinical and biological research"},{"issue":"15","key":"10.1002\/14651858.CD010561.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM198804143181503","article-title":"Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII.","volume":"318","author":"Nilsson","year":"1988","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD010561.pub2-BIB0034|cit34","first-page":"1288","article-title":"Immune tolerance induction with highly purified plasma-derived factor VIII containing von Willebrand factor in hemophilia A patients with high-responding inhibitors","volume":"90","author":"Orsini","year":"2005","journal-title":"Haematologica"},{"issue":"2","key":"10.1002\/14651858.CD010561.pub2-BIB0035|cit35","first-page":"412, Abstract n","article-title":"Optimum response to treatment of immunotolerance with octocog alfa\u00a0 [abstract]","volume":"16","author":"Palomo","year":"2010","journal-title":"Haemophilia"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0036|cit36","first-page":"1133, Abstract","article-title":"Successful tolerization with high von Willebrand factor\/factor VIII content ratio concentrate of children with severe haemophilia A and high responding inhibitor\u00a0[abstract]","volume":"7 Suppl 2","author":"Platokouki","year":"2009","journal-title":"Journal of Thrombosis & Haemostasis"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0037|cit37","unstructured":"Prentice CR Comparison of factor VIII and prothrombin complex concentrates in the treatment of inhibitor patients Progress in Clinical and Biological Research 1984 197 206"},{"issue":"3","key":"10.1002\/14651858.CD010561.pub2-BIB0038|cit38","first-page":"568","article-title":"The use of a VWF containing plasma derived FVIII product (VWF\/pd-FVIII) in inhibitor patients for rescue immune tolerance induction (ITI)","volume":"17","author":"Puetz","year":"2011","journal-title":"Haemophilia"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1423-0410.1999.tb00018.x","article-title":"Successful immune tolerance treatment with monoclonal or recombinant factor VIII concentrates in high responding inhibitor patients","volume":"77 Suppl 1","author":"Rocino","year":"1999","journal-title":"Vox Sanguinis"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0040|cit40","first-page":"62, Abstract no","article-title":"Immune tolerance induction with recombinant factor VIII in hemophilia A patients with inhibitors [abstract]","volume":"10 Suppl 3","author":"Rocino","year":"2004","journal-title":"Haemophilia"},{"issue":"5","key":"10.1002\/14651858.CD010561.pub2-BIB0041|cit41","first-page":"779","article-title":"French previously untreated patients with severe hemophilia A after exposure to recombinant factor VIII : incidence of inhibitor and evaluation of immune tolerance","volume":"80","author":"Rothschild","year":"1998","journal-title":"Thrombosis Haemostasis"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0042|cit42","first-page":"s86","article-title":"High purity VWF\/FVIII complex concentrate in primary or rescue immune tolerance induction: Large scale, multicenter international study [abstract]","volume":"10","author":"Santagostino","year":"2012","journal-title":"Blood Transfusion"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0043|cit43","first-page":"63, Abstract no","article-title":"Immune tolerance protocol with an intermediate purity factor VIII cocentrate for the treatment of severe haemophilia A with factor VIII inhibitor\u00a0 [abstract]","volume":"10 Suppl 4","author":"Scaraggi","year":"2004","journal-title":"Haemophilia"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0044|cit44","unstructured":"Seremetis SV The clinical use of factor VIIa in the treatment of factor VIII inhibitor patients Seminars in Hematology 1994 53 5"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0045|cit45","doi-asserted-by":"crossref","unstructured":"Shapiro AD Gilchrist GS Hoots WK Cooper HA Gastineau DA Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery Thrombosis and Haemostasis 1998 773 8","DOI":"10.1055\/s-0037-1615357"},{"issue":"1","key":"10.1002\/14651858.CD010561.pub2-BIB0046|cit46","first-page":"S119","article-title":"Immune tolerance induction with high-dose FVIII and pulsed intravenous immunoglobulin","volume":"30","author":"Stiefel","year":"2010","journal-title":"Hamostaseologie"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0047|cit47","first-page":"52, Abstract no","article-title":"Interim results of immune tolerance induction in children with an inhibitory form of hemophilia A\u00a0 [abstract]","volume":"14 Suppl 2","author":"Svirin","year":"2008","journal-title":"Haemophilia"},{"issue":"3","key":"10.1002\/14651858.CD010561.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1046\/j.1365-2516.2000.00379.x","article-title":"Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors","volume":"6","author":"Unuvar","year":"2000","journal-title":"Haemophilia"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0049|cit49","first-page":"16, Abstract no","article-title":"Experience with a third generation recombinant factor VIII concentrate (Advate(R)) for immune tolerance induction in patients with hemophilia A [abstract]","volume":"14 Suppl 2","author":"Valentino","year":"2008","journal-title":"Haemophilia"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0050|cit50","first-page":"96","article-title":"Inhibitor eradication therapy in non-severe hemophilia A [abstract]","volume":"18","author":"Velzen","year":"2012","journal-title":"Haemophilia"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0051|cit51","first-page":"207, Abstract n","article-title":"Inhibitor eradication therapy in non-severe hemophilia A\u00a0[abstract]","volume":"11 Suppl 2","author":"Velzen","year":"2013","journal-title":"Journal of Thrombosis & Haemostasis"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0053|cit52","first-page":"1127, Abstract","article-title":"Treatment of haemophilia A patients with inhibitors and a poor prognosis: ITI with octanate(R) [abstract]","volume":"7 Suppl 2","author":"Zozulya","year":"2009","journal-title":"Journal of Thrombosis & Haemostasis"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0052|cit53","first-page":"150, Abstract n","article-title":"The Octanate(R) immune tolerance induction experience in haemophilia A patients with inhibitors and a poor prognosis: prospective post-marketing study in progress [abstract]","volume":"14 Suppl 2","author":"Zozulya","year":"2008","journal-title":"Haemophilia"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0054|cit54","unstructured":"NCT01051544 Study of First TIME Immunotolerance Induction in Severe Hemophilia A Patients With Inhibitor at High Risk of Failure: Comparison With FVIII Concentrates With or Without Von Willebrand Factor - RES.I.S.T. Naive (RESIST NAIVE) clinicaltrials.gov\/show\/NCT01051544"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.thromres.2010.10.006","article-title":"Immune tolerance induction in patients with hemophilia A","volume":"127 Suppl 1","author":"Astermark","year":"2011","journal-title":"Thrombosis Research"},{"issue":"7","key":"10.1002\/14651858.CD010561.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1055\/s-0033-1356574","article-title":"Challenges in the Management of Hemophilia B with Inhibitor","volume":"39","author":"Batorova","year":"2013","journal-title":"Seminars in Thrombosis and Haemostasis"},{"issue":"5","key":"10.1002\/14651858.CD010561.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1600-0609.2012.01754.x","article-title":"Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practice","volume":"88","author":"Benson","year":"2012","journal-title":"European Journal of Haematology"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0058|cit58","first-page":"48","article-title":"Immune tolerance induction and the treatment of hemophilia. Malmo protocol update","volume":"85 Suppl 10","author":"Berntorp","year":"2000","journal-title":"Haematologica"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0059|cit59","first-page":"1","article-title":"The long-term course of factor VIII inhibitors in patients with congenital haemophilia A without immune tolerance induction","volume":"105","author":"Caram","year":"2010","journal-title":"Blood Coagulation, Fibrinolysis and Cellular Haemostasis"},{"issue":"1","key":"10.1002\/14651858.CD010561.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2516.2005.01170.x","article-title":"Rituximab for congenital haemophiliacs with inhibitors: a Canadian experience","volume":"12","author":"Carcao","year":"2006","journal-title":"Haemophilia"},{"issue":"11","key":"10.1002\/14651858.CD010561.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1111\/j.1538-7836.2009.03615.x","article-title":"Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors","volume":"7","author":"Coppola","year":"2009","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2147\/JBM.S6885","article-title":"Treatment of hemophilia: a review of current advances and ongoing issues","volume":"1","author":"Coppola","year":"2010","journal-title":"Journal of Blood Medicine"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0063|cit63","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors).\u00a0 Cochrane Handbook for Systematic Reviews of Interventions \u00a0Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1538-7836.2011.04349.x","article-title":"Immune tolerance induction in haemophilia: evidence and the way forward","volume":"9 Suppl 1","author":"Michele","year":"2011","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"1","key":"10.1002\/14651858.CD010561.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1365-2516.2009.02100.x","article-title":"Cost of care of haemophilia with inhibitors","volume":"16","author":"Minno","year":"2010","journal-title":"Haemophilia"},{"issue":"3","key":"10.1002\/14651858.CD010561.pub2-BIB0066|cit66","first-page":"305","article-title":"Inhibitor development in haemophilia B: an orphan disease in need of attention","volume":"138","author":"DiMichele","year":"2007","journal-title":"British Journal of Haemophilia"},{"issue":"1","key":"10.1002\/14651858.CD010561.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2516.2008.01880.x","article-title":"The North American Immune Tolerance Registry: Contributions to the thirty-year experience with immune tolerance therapy","volume":"15","author":"DiMichele","year":"2009","journal-title":"Haemophilia"},{"issue":"7109","key":"10.1002\/14651858.CD010561.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD010561.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11239-011-0624-3","article-title":"Immune tolerance induction for patients with severe hemophilia A: a critical literature review","volume":"32","author":"Franchini","year":"2011","journal-title":"Journal of Thrombosis and Thrombolysis"},{"issue":"11","key":"10.1002\/14651858.CD010561.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1046\/j.1537-2995.2003.00559.x","article-title":"Immunoadsorption may provide a cost-effective approach to management of patients with inhibitors to FVIII","volume":"43","author":"Freedman","year":"2003","journal-title":"Transfusion"},{"issue":"5","key":"10.1002\/14651858.CD010561.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"327\u201333","DOI":"10.1097\/01.moh.0000139998.68132.d2","article-title":"Immunoadsorption of factor VIII inhibitors","volume":"11","author":"Freedman","year":"2004","journal-title":"Current Opinion in Hematology"},{"issue":"7","key":"10.1002\/14651858.CD010561.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1182\/blood-2003-03-0941","article-title":"Cost of care and quality of life for patients with haemophilia complicated by inhibitors: the COCIS Study Group","volume":"102","author":"Gringeri","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1002\/14651858.CD010561.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1046\/j.1365-2516.2001.00469.x","article-title":"Immune tolerance treatment in haemophilia patients with inhibitors: the Spanish registry","volume":"7","author":"Haya","year":"2001","journal-title":"Haemophilia"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0074|cit74","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors).\u00a0 Cochrane Handbook for Systematic Reviews of Interventions \u00a0Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"8","key":"10.1002\/14651858.CD010561.pub2-BIB0075|cit75","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004449.pub3","article-title":"Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitors","author":"Iorio","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2516.2006.01371.x","article-title":"Overview of the use of implantable venous access devices in the management of children with inherited bleeding disorders","volume":"12 S6","author":"Komvilaisak","year":"2006","journal-title":"Haemophilia"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0077|cit77","unstructured":"Kreuz W Escuriola-Ettingshausen C Observational Immune Tolerance Induction (ObsITI) research program www.obsiti.com"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1423-0410.1999.tb00011.x","article-title":"Comparison of the international immune tolerance registry and the North American immune tolerance registry","volume":"77 Suppl 1","author":"Kroner","year":"1999","journal-title":"Vox Sang"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0079|cit79","first-page":"45","article-title":"The German registry of immune tolerance treatment in hemophilia-1999 update","volume":"85 Suppl 10","author":"Lenk","year":"2000","journal-title":"Haematologica"},{"issue":"23","key":"10.1002\/14651858.CD010561.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJM200106073442307","article-title":"The Hemophilias-- from royal genes to gene therapy","volume":"344","author":"Mannucci","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1423-0410.1999.tb00008.x","article-title":"International Immune Tolerance Registry, 1997 Update","volume":"77 Suppl 1","author":"Mariani","year":"1999","journal-title":"Vox Sanguinis"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0082|cit82","unstructured":"NCT01051076 Rescue Immunotolerance Study in Induction of Immune Tolerance (ITI)-Experienced Patients (RES.I.S.T. Experienced) linicaltrials.gov\/show\/NCT01051076"},{"issue":"1","key":"10.1002\/14651858.CD010561.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1185\/03007990802633863","article-title":"Optimizing immune tolerance induction strategies in the management of haemophilia patients with inhibitors: a cost minimization analysis","volume":"25","author":"Odeyemi","year":"2009","journal-title":"Current Medical Reserach and Opinion"},{"issue":"2","key":"10.1002\/14651858.CD010561.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2516.2006.01204.x","article-title":"Quality of life associated to the orthopaedic status in haemophilic patients with inhibitors","volume":"12","author":"Scalone","year":"2006","journal-title":"Haemophilia"},{"key":"10.1002\/14651858.CD010561.pub2-BIB0085|cit85","unstructured":"Shemilt I Mugford M Byford S Drummond M Eisenstein E Knapp M Chapter 15: Incorporating economics evidence. In: Higgins JPT, Green S (editors),\u00a0 Cochrane Handbook for Systematic Reviews of Interventions \u00a0Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"63","key":"10.1002\/14651858.CD010561.pub2-BIB0086|cit86","first-page":"1","article-title":"High rate of spontaneous inhibitor clearance during the long term observation study of a single cohort of 524 haemophilia A patients not undergoing immunotolerance","volume":"6","author":"Tagariello","year":"2013","journal-title":"Journal of Hematology and Oncology"},{"issue":"3","key":"10.1002\/14651858.CD010561.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2516.2009.02188.x","article-title":"Mortality and causes of death in Italian persons with haemophilia, 1990 - 2007","volume":"16","author":"Tagliaferri","year":"2010","journal-title":"Haemophilia"},{"issue":"4","key":"10.1002\/14651858.CD010561.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1046\/j.1365-2516.2003.00781.x","article-title":"Immune tolerance induction in patients with haemophilia A with inhibitors: a systematic review","volume":"9","author":"Wight","year":"2003","journal-title":"Haemophilia"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD010561.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T23:42:45Z","timestamp":1723678965000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010561.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,4,24]]},"references-count":88,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010561.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,24]]}}}